- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Diaceutics PLC (DXRX)
The Diaceutics share price today is 165.50, view LON DXRX stock exchange data. Track the latest Diaceutics share price with real-time updates on DXRX stock performance including market cap, day range, 52-week range and dividend yield. Access DXRX charts, earnings dates and analyst estimates to support your investment decisions.
London
Currency in GBP
165.50
-7.00(-4.06%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
165.00
170.55
52 wk Range
112.25
177.00
DXRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
165.00170.55
52 wk Range
112.25177.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DXRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
220.60
Upside
+33.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Diaceutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Diaceutics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 220.60
(+33.29% Upside)
Earnings
Latest Release
15-01-2026
EPS / Forecast
0.03 / 0.04
Revenue / Forecast
24M / 24.49M
Compare DXRX to Peers and Sector
Metrics to compare | DXRX | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipDXRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −96.1x | −6.0x | −0.5x | |
PEG Ratio | −1.33 | −0.13 | 0.00 | |
Price/Book | 3.9x | 2.2x | 2.6x | |
Price / LTM Sales | 4.2x | 4.5x | 3.2x | |
Upside (Analyst Target) | 30.4% | 187.5% | 50.8% | |
Fair Value Upside | Unlock | 2.2% | 7.7% | Unlock |
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Diaceutics (DXRX) Share Price Today?
The Diaceutics share price today is 165.50.
What is the current Diaceutics (DXRX) share price and day range?
As of 30-04-2026, the Diaceutics share price is 165.50, with a previous close of 172.50. The share price has ranged from 165.00 to 170.55 today, while the 52-week range spans from 112.25 to 177.00.
What Is the Diaceutics Market Cap?
As of today, Diaceutics market cap is 140.10M.
What Is the Diaceutics (DXRX) Share Price Target?
The average 12-month share price target for Diaceutics is 220.60, with a high estimate of 243 and a low estimate of 185. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +33.29% Upside potential.
What Is Diaceutics's Earnings Per Share (TTM)?
The Diaceutics EPS (TTM) is -0.02.
When Is the Next Diaceutics Earnings Date?
Diaceutics will release its next earnings report on 24-03-2026.
From a Technical Analysis Perspective, Is DXRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Diaceutics Trade On?
Diaceutics is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Diaceutics?
The stock symbol for Diaceutics is "DXRX."
How Many Times Has Diaceutics Stock Split?
Diaceutics has split 0 times.
How Many Employees Does Diaceutics Have?
Diaceutics has 213 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.